HCA Healthcare (NYSE:HCA) Given New $485.00 Price Target at Oppenheimer

HCA Healthcare (NYSE:HCA) had its price target dropped by research analysts at Oppenheimer from $520.00 to $485.00 in a report issued on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s target price points to a potential upside of 26.30% from the stock’s current price.

HCA has been the topic of several other research reports. Robert W. Baird reduced their price target on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a report on Monday. Wells Fargo & Company set a $369.00 target price on shares of HCA Healthcare in a research note on Monday, July 20th. Cantor Fitzgerald cut their price target on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a report on Tuesday, July 7th. KeyCorp lowered their price objective on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a research report on Monday. Finally, Weiss Ratings downgraded HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 9th. Fourteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $477.14.

HCA Healthcare Trading Up 0.5%

HCA stock opened at $384.00 on Monday. The company has a market cap of $85.19 billion, a price-to-earnings ratio of 12.86, a PEG ratio of 1.29 and a beta of 1.12. The firm has a 50-day moving average of $386.95 and a two-hundred day moving average of $453.56. HCA Healthcare has a 12 month low of $331.61 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the firm earned $6.84 earnings per share. As a group, equities analysts forecast that HCA Healthcare will post 29.19 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Sumitomo Life Insurance Co. boosted its stake in shares of HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after buying an additional 20 shares during the period. MJP Associates Inc. ADV raised its holdings in HCA Healthcare by 2.9% in the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after acquiring an additional 21 shares in the last quarter. Cary Street Partners Investment Advisory LLC grew its holdings in HCA Healthcare by 7.5% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after acquiring an additional 21 shares in the last quarter. Anchyra Partners LLC raised its holdings in shares of HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after purchasing an additional 21 shares in the last quarter. Finally, Plato Investment Management Ltd grew its stake in shares of HCA Healthcare by 0.6% during the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after purchasing an additional 22 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.